R.H. Bluestein & Co’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $380K | Hold |
10,000
| – | – | 0.02% | 189 |
|
|
2022
Q2 | $500K | Hold |
10,000
| – | – | 0.03% | 163 |
|
|
2022
Q1 | $513K | Hold |
10,000
| – | – | 0.02% | 185 |
|
|
2021
Q4 | $501K | Sell |
10,000
-2,500
| -20% | -$124K | 0.02% | 214 |
|
|
2021
Q3 | $603K | Hold |
12,500
| – | – | 0.02% | 187 |
|
|
2021
Q2 | $658K | Hold |
12,500
| – | – | 0.03% | 187 |
|
|
2021
Q1 | $618K | Hold |
12,500
| – | – | 0.03% | 175 |
|
|
2020
Q4 | $607K | Hold |
12,500
| – | – | 0.03% | 162 |
|
|
2020
Q3 | $627K | Hold |
12,500
| – | – | 0.03% | 134 |
|
|
2020
Q2 | $638K | Hold |
12,500
| – | – | 0.04% | 122 |
|
|
2020
Q1 | $547K | Hold |
12,500
| – | – | 0.05% | 113 |
|
|
2019
Q4 | $628K | Hold |
12,500
| – | – | 0.03% | 130 |
|
|
2019
Q3 | $579K | Hold |
12,500
| – | – | 0.03% | 135 |
|
|
2019
Q2 | $541K | Hold |
12,500
| – | – | 0.03% | 138 |
|
|
2019
Q1 | $554K | Hold |
12,500
| – | – | 0.03% | 125 |
|
|
2018
Q4 | $543K | Sell |
12,500
-2,500
| -17% | -$110K | 0.04% | 100 |
|
|
2018
Q3 | $670K | Hold |
15,000
| – | – | 0.03% | 122 |
|
|
2018
Q2 | $600K | Hold |
15,000
| – | – | 0.03% | 126 |
|
|
2018
Q1 | $601K | Hold |
15,000
| – | – | 0.03% | 133 |
|
|
2017
Q4 | $645K | Hold |
15,000
| – | – | 0.03% | 123 |
|
|
2017
Q3 | $747K | Hold |
15,000
| – | – | 0.04% | 109 |
|
|
2017
Q2 | $719K | Sell |
15,000
-6,500
| -30% | -$311K | 0.04% | 96 |
|
|
2017
Q1 | $973K | Buy |
21,500
+1,500
| +8% | +$63.6K | 0.06% | 78 |
|
|
2016
Q4 | $809K | Hold |
20,000
| – | – | 0.05% | 88 |
|
|
2016
Q3 | $764K | Hold |
20,000
| – | – | 0.05% | 81 |
|
|
2016
Q2 | $837K | Hold |
20,000
| – | – | 0.06% | 68 |
|
|
2016
Q1 | $803K | Hold |
20,000
| – | – | 0.06% | 88 |
|
|
2015
Q4 | $853K | Hold |
20,000
| – | – | 0.05% | 84 |
|
|
2015
Q3 | $949K | Hold |
20,000
| – | – | 0.07% | 84 |
|
|
2015
Q2 | $991K | Sell |
20,000
-100
| -0.5% | -$5.07K | 0.06% | 95 |
|
|
2015
Q1 | $994K | Buy |
20,100
+100
| +0.5% | +$4.78K | 0.06% | 90 |
|
|
2014
Q4 | $912K | Sell |
20,000
-100
| -0.5% | -$4.85K | 0.06% | 103 |
|
|
2014
Q3 | $1.13M | Buy |
20,100
+100
| +0.5% | +$5.37K | 0.07% | 98 |
|
|
2014
Q2 | $1.06M | Hold |
20,000
| – | – | 0.06% | 110 |
|
|
2014
Q1 | $1.05M | Sell |
20,000
-5,500
| -22% | -$278K | 0.07% | 110 |
|
|
2013
Q4 | $1.37M | Buy |
25,500
+500
| +2% | +$25.8K | 0.09% | 83 |
|
|
2013
Q3 | $1.27M | Sell |
25,000
-25
| -0.1% | -$1.27K | 0.09% | 90 |
|
|
2013
Q2 | $1.29M | Buy |
+25,025
| New | +$1.33M | 0.11% | 80 |
|
Other funds holding SNY
CCM
R.H. Bluestein & Co's SNY Position: Q3 2022 in Review
R.H. Bluestein & Co held its Sanofi (SNY) position steady in Q3 2022 at 10,000 shares worth $380K. The position accounts for 0.02% of the portfolio, ranked #189.
R.H. Bluestein & Co first reported a position in SNY in Q2 2013 and has held it in 38 quarters since. The position peaked at $1.37M in Q4 2013. 587 funds tracked by Wall St. Rank hold SNY as of Q3 2022.
- R.H. Bluestein & Co held 10,000 shares of Sanofi worth $380K as of Q3 2022.
- R.H. Bluestein & Co left its Sanofi share count unchanged in Q3 2022.
- Sanofi made up 0.02% of R.H. Bluestein & Co's portfolio in Q3 2022, its #189 holding.
- R.H. Bluestein & Co first reported a position in Sanofi in Q2 2013 and has held it in 38 quarters since.
- R.H. Bluestein & Co's Sanofi position peaked at $1.37M in Q4 2013.
- 587 funds tracked by Wall St. Rank held Sanofi as of Q3 2022.
Based on R.H. Bluestein & Co's 13F filing for Q3 2022, filed 14 Nov 2022.